Concepedia

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Esther Meijer, Joost P.H. Drenth, Hedwig M. A. D‘Agnolo, Niek F. Casteleijn, Johan W. de Fijter, Tom J.G. Gevers, Peter Kappert, Dorien J.M. Peters, Mahdi Salih, Darius Soonawala,

American Journal of Kidney Diseases · 2013 · 70 citations · 44 references

DOIFull text

Open access

Concepts

References

44

A simplified equation to predict glomerular filtration rate from serum creatinine

Andrew S. Levey, Juan P. Bosch, J B Lewis et al. · Journal of the American Society of Nephrology · 2000 · 1.7K citations

, , +14

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.6K citations · Full text

, , +14

<b> <i>PKD2</i> </b> , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein

Toshio Mochizuki, Guanqing Wu, Tomohito Hayashi et al. · Science · 1996 · 1.4K citations

, , +17

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

Jonathan M. Shillingford, Noel Murcia, Claire H. Larson et al. · Proceedings of the National Academy of Sciences · 2006 · 798 citations · Full text

, , +15

Unified Criteria for Ultrasonographic Diagnosis of ADPKD

York Pei, James Obaji, Annie Dupuis et al. · Journal of the American Society of Nephrology · 2008 · 751 citations · Full text

, , +17